As of January 22, 2025, Immix Biopharma (IMMX) has a market cap of $54.465 million USD. According to our data, Immix Biopharma is ranked No.8102 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $54.47 M |
-10.00%
|
Dec 31, 2024 | $60.52 M |
-68.21%
|
Dec 29, 2023 | $0.19 B |
202.18%
|
Dec 30, 2022 | $62.99 M |
-35.67%
|
Dec 31, 2021 | $97.93 M |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Gilead Sciences
GILD
|
$115.95 B |
0.002 M
|
USA
|
Amgen
AMGN
|
$146.98 B |
0.004 M
|
USA
|
Bristol-Myers Squibb
BMY
|
$115.79 B |
-0.003 M
|
USA
|
Regeneron Pharmaceuticals
REGN
|
$74.73 B |
1.236 B
|
USA
|
Biogen
BIIB
|
$20.80 B |
0.000 M
|
USA
|
Moderna
MRNA
|
$14.82 B |
-0.000 M
|
USA
|
BioMarin Pharmaceutical
BMRN
|
$11.82 B |
0.000 M
|
USA
|
Incyte
INCY
|
$13.95 B |
-0.000 M
|
USA
|
Alnylam Pharmaceuticals
ALNY
|
$34.38 B |
-0.000 M
|
USA
|
Sarepta Therapeutics
SRPT
|
$11.09 B |
0.000 M
|
USA
|
Ionis Pharmaceuticals
IONS
|
$5.13 B |
-0.000 M
|
USA
|
Blueprint Medicines
BPMC
|
$7.06 B |
-0.000 M
|
USA
|
CRISPR Therapeutics
CRSP
|
$3.77 B |
-0.000 M
|
Switzerland
|
Market Cap | = | IMMX Stock Price | * | IMMX Shares Outstanding |
= | $1.98 | * | 27.51 M | |
= | $54.47 M |